Clinical Takeaway CBD-based treatments, particularly cannabidiol-rich preparations, showed measurable reductions in behavioral symptoms such as hyperactivity, self-injury, and rage attacks in children with autism spectrum disorder across multiple reviewed trials. Improvements in...
Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness.
Autism spectrum disorder (ASD) lacks effective options for core symptoms. Cannabinoids, especially cannabidiol (CBD) and combined CBD:ฮ9-tetrahydrocannabinol…
Maternal Cannabis & Autism/ADHD Risk: Clinical Evidence
Clinical Takeaway Children born to mothers who used cannabis during pregnancy showed a modestly elevated risk for autism spectrum disorder and a smaller increase in risk for ADHD, based on a meta-analysis...
Pilot Study Finds Salivary Metabolite Shifts in Autistic Children Treated with Medical CannabisโBut Evidence Remains Preliminary
“Sixty-five potential cannabis-responsive biomarkers exhibiting a shift toward the TD physiological levels were identified in children with ASD after MC treatment.” โ Authors’ caution that larger trials are needed is appropriate, but the term ‘Cannabis-Responsive’ implies causation the design cannot support.
Rigorous CBD Trial for Autism Behavioral Symptoms LaunchesโBut Results Are Not Yet In
There is a significant need for clinical research exploring alternative medications for the treatment of behavioral symptoms of ASD. Cannabidiol (CBD) is being studied for the management of irritability, aggression, and other problem behaviors associated with ASD.
Cannabinoids Show Modest, Low-Certainty Benefits for a Few Mental Health ConditionsโBut Widespread Clinical Use Is Not Justified
Given the scarcity of evidence, the routine use of cannabinoids for the treatment of mental disorders and SUDs is currently rarely justified.
Endocannabinoid System Research: Cannabis & Autism Risk
Clinical Takeaway Children exposed to cannabis during the peripregnancy period showed associations with behavioral and developmental differences in offspring, with effects varying based on whether children had ASD symptoms. These findings suggest...
Endocannabinoid System Research: Cannabis for Autism
Clinical Takeaway Across randomized clinical trials, cannabis derivatives and their analogs showed promising early signals for improving core and associated symptoms of autism spectrum disorder, including social communication and behavioral challenges. The...
Endocannabinoid System Research: Cannabis Use & Child ASD
Clinical Takeaway Children exposed to cannabis during the peripregnancy period showed associations with behavioral and developmental differences in early childhood, and these associations varied depending on whether ASD symptoms were present. The...
Endocannabinoid System: Cannabis Use & Child Development
Clinical Takeaway Maternal cannabis use during the peripregnancy period was associated with behavioral and developmental differences in children, with effects varying depending on whether the child showed symptoms of autism spectrum disorder....